Page last updated: 2024-09-04

cyc 202 and THZ531

cyc 202 has been researched along with THZ531 in 2 studies

Compound Research Comparison

Studies
(cyc 202)
Trials
(cyc 202)
Recent Studies (post-2010)
(cyc 202)
Studies
(THZ531)
Trials
(THZ531)
Recent Studies (post-2010) (THZ531)
979739319018

Protein Interaction Comparison

ProteinTaxonomycyc 202 (IC50)THZ531 (IC50)
Cyclin-T1Homo sapiens (human)0.5135
Cyclin-KHomo sapiens (human)0.2656
Cyclin-A2Homo sapiens (human)1.3
Cyclin-dependent kinase 2Homo sapiens (human)1.3
Cyclin-dependent kinase 7Homo sapiens (human)4.4025
Cyclin-dependent kinase 9Homo sapiens (human)0.5135
Cyclin-HHomo sapiens (human)5.8173
CDK-activating kinase assembly factor MAT1Homo sapiens (human)8.5
Cyclin-dependent kinase 13Homo sapiens (human)0.265
Cyclin-dependent kinase 12Homo sapiens (human)2.3247

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
de Dios, A; Lallena, MJ; Sánchez-Martínez, C; Sanfeliciano, SG1
Diab, S; Wang, S; Yu, M1

Reviews

2 review(s) available for cyc 202 and THZ531

ArticleYear
Cyclin dependent kinase (CDK) inhibitors as anticancer drugs: Recent advances (2015-2019).
    Bioorganic & medicinal chemistry letters, 2019, 10-15, Volume: 29, Issue:20

    Topics: Aminopyridines; Animals; Antineoplastic Agents; Benzimidazoles; Breast Neoplasms; Cell Cycle Checkpoints; Cyclin-Dependent Kinases; Drug Discovery; Humans; Indoles; Piperazines; Protein Kinase Inhibitors; Purines; Pyridines; Pyrimidines; Transcription Factors

2019
CDK7 Inhibitors in Cancer Therapy: The Sweet Smell of Success?
    Journal of medicinal chemistry, 2020, 07-23, Volume: 63, Issue:14

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase-Activating Kinase; Cyclin-Dependent Kinases; Humans; Neoplasms; Protein Kinase Inhibitors

2020